UK-Russia roundtable discussion – Antimicrobial resistance (AMR): dialogue between sectors
17-18 December 2015, Smolensk & Moscow, Russia
A high-level roundtable on policy, research, and collaboration in the field of AMR was organised between the UK and Russia by the UK Science & Innovation Network (SIN)-Russia of the British Embassy in Moscow and the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC) in Smolensk (Russia).
Held 17-18 December 2015, the roundtable brought together leaders from Russian and UK medical science, innovation funders, along with academies, government departments and business to forge closer links and to promote mutual understanding of each other’s organisations, research landscapes and priorities.
Through a mixture of formal presentations and informal interactions, the event aimed to build a stronger foundation for future scientific and policy collaboration between the two countries. The outcomes of this meeting will aide and inform UK and Russian stakeholders as they work to agree an effective programme of cooperation, while implementing the Antimicrobial Resistance Global Action Plan.
An introduction to the inter-sectorial dialogue between Russia and the UK on antimicrobial resistance:
Video presentation by Professor Dilip Nathwani, President, BSAC
Programme & Presentations
Thursday, 17 December 2015 - Smolensk
0930
Welcome and introduction to IACMAC programs, AMR Centre in Smolensk and current situation in Russia
Professor Roman Kozlov
Chief Specialists on Clinical Microbiology and AMR, RF Ministry of Health, President of IACMAC
1000
Introduction and the latest developments in their clinical practice, education, surveillance, research & policy areas
Dr Danilo Lo Fo Wong
Program Manager Control of AMR, Communicable Diseases, Health Security, and Environment World Health Organization Regional Office for Europe, WHO
Professor Dilip Nathwani
President, British Society for Antimicrobial Chemotherapy
Professor Neil Woodford
Head, AMRHAI Reference Unit, PHE
Professor Shabbir Simjee
Co-Chair of CLSI Veterinary AST Sub-Committee and Past Chair of VetPath, ELANCO
Friday, 18 December 2015 - Moscow
1000
Welcoming and challenges in Russia and UK
Professor Dilip Nathwani
President, British Society for Antimicrobial Chemotherapy
Professor John Watson
Deputy Chief Medical Officer, England (DCMO), Department of Health, UK
1020
Situation analysis in Russia on general capacity for tackling AMR (Key statistics and national programs & Case studies of infections and AMR monitoring system in action)
Dr Andrey V. Dekhnich
Institute of Antimicrobial Chemotherapy at the Smolensk State Medical University
1030
Infectious diseases & AMR monitoring and reporting AMR cases in Russia (Standards/procedures/protocols in collecting information on infectious diseases and AMR)
Dr Michael Eidelstein
Institute of Antimicrobial Chemotherapy at the Smolensk State Medical University
1040
Situation analysis in the UK on general capacity for tackling AMR & Infectious diseases & AMR monitoring and reporting AMR cases in the UK (Key statistics and national programs & case studies of infections and AMR monitoring system in action in the UK & AMR stewardship programs; Standards/procedures/protocols in collecting information on infectious diseases and AMR)
Professor John Watson
Deputy Chief Medical Officer, England (DCMO), Department of Health, UK
Dr Susan Hopkins
Consultant in Infectious Diseases & Microbiology, Royal Free London NHS Foundation Trust, Healthcare Epidemiologist, Public Health England, Honorary Senior Lecturer, University College London
1100
Improving quality of antibiotic prescribing through stewardship (Key development in national stewardship, surveillance of consumption, measurement, and professional education)
1110
Pharma view on AMR and economic environment for antibiotics production
Mr Tim Mepham
Infection Environmental Lead, AstraZeneca, UK & Moscow office reps
Dr Vladimir Bulatov1 & Dr Kamil Saytkulov2
1GSK Russia Country Medical Director, 2Head GR, Moscow office
1130
AMR situation analysis and monitoring system in veterinary in the UK
1140
AMR monitoring in Veterinary medicine – Industry Initiatives
Professor Shabbir Simjee
& Mr Rashid Doole, Anna Plokhova, ELANCO
1220
WHO initiatives to build global surveillance capacity
Dr Danilo Lo Fo Wong
Program Manager Control of AMR, Communicable Diseases, Health Security, and Environment World Health Organization Regional Office for Europe, WHO
1230
Implementation of action plans on the national and global levels & ways to slow down AMR spreading &vaccines in medicine & veterinary
Professor Roman Kozlov
Chief Specialists on Clinical Microbiology and AMR, RF Ministry of Health, President of IACMAC
Professor John Watson
Deputy Chief Medical Officer, England (DCMO), Department of Health, UK
Professor Peter Borriello
CEO of the Veterinary Medicines Directorate, DEFRA, UK
1300
Possible cooperation in harmonisation of action plans, policy of surveillance of antibiotics use & consumption in UK and Russia
Professor Lyalya Gabbasova
RF Health Ministry
Professor Dilip Nathwani
President, British Society for Antimicrobial Chemotherapy
Dr Svetlana Ratchina
Institute of Antimicrobial Chemotherapy at the Smolensk State Medical University